Cambrian BioPharma Inc
Industry: Biotechnology (See others in industry)
Address:
228 Park Avenue South Suite 66643
New York, NY, 10003
Phone: (516) 962-3186
New York, NY, 10003
Phone: (516) 962-3186
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-07-15 | New | $123,751,064 | $123,751,064 | Equity Only | 06c | SEC link |
| 2025-01-13 | Amended | $23,022,065 | $15,330,232 | Other | 06b | SEC link |
| 2023-12-22 | New | $7,691,833 | $7,691,833 | Other | 06b | SEC link |
| 2021-12-02 | New | $92,209,653 | $92,209,653 | Equity Only | 06b | SEC link |
| 2021-05-06 | New | $28,434,938 | $28,434,938 | Equity and Debt | 06b | SEC link |
| 2020-01-27 | New | $4,750,000 | $4,750,000 | Equity Only | 06b | SEC link |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Christian Angermayer | Director |
| Christian Angermeyer | Director |
| William De Vaul | Executive |
| Paul Farr | Director |
| Martin Gunhaga | Director |
| Juliette Han | Director, Executive |
| Mark Nuttall | Executive |
| James Peyer | Director, Executive |
| Maryanna Saenko | Director |
| Brenton L. Saunders | Director |
| Ruth Thieroff Ekerdt | Executive |
| Lorin Van Nuland | Director |